Pheon Therapeutics

Pheon Therapeutics is a preclinical-stage oncology biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat solid tumors. Leveraging two decades of ADC experience, Pheon arms monoclonal antibodies against both novel and clinically validated targets with warheads from its proprietary payload platform, which offers a novel mechanism of action, or with off-the-shelf linker-payload combinations, balancing safety and efficacy for each target. The company is privately held and backed by specialist healthcare investors. Pheon publishes a corporate and scientific web presence only; it exposes no public developer API, SDKs, documentation, or well-known API discovery surface.

Pheon Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Antibody-Drug Conjugates.

Pheon Therapeutics’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyAntibody-Drug ConjugatesDrug DevelopmentHealthcareCancer Therapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/pheon-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Pheon Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 BlogRSS
BlogRSS

Source (apis.yml)

apis.yml Raw ↑ 
aid: pheon-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/pheon-therapeutics.png
name: Pheon Therapeutics
description: Pheon Therapeutics is a preclinical-stage oncology biotechnology company developing next-generation antibody-drug
  conjugates (ADCs) for a wide range of hard-to-treat solid tumors. Leveraging two decades of ADC experience, Pheon arms monoclonal
  antibodies against both novel and clinically validated targets with warheads from its proprietary payload platform, which
  offers a novel mechanism of action, or with off-the-shelf linker-payload combinations, balancing safety and efficacy for
  each target. The company is privately held and backed by specialist healthcare investors. Pheon publishes a corporate and
  scientific web presence only; it exposes no public developer API, SDKs, documentation, or well-known API discovery surface.
url: https://raw.githubusercontent.com/api-evangelist/pheon-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Antibody-Drug Conjugates
- Drug Development
- Healthcare
- Cancer Therapeutics
apis: []
common:
- type: DomainSecurity
  url: security/pheon-therapeutics-domain-security.yml
- type: Website
  url: https://pheontx.com/
- type: Blog
  url: https://pheontx.com/news-events/
- type: BlogRSS
  url: https://pheontx.com/feed/
- type: Support
  url: https://pheontx.com/contact/
- type: PrivacyPolicy
  url: https://pheontx.com/privacy-policy/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1